Dysphagia Cafe Blog

Continuing Education

Dysphagia CafeMay 9, 2021

A Tale of Two Swallows: A Case-Based Comparison of Dysphagia Evaluation and Management

Continuing EducationHead Neck Cancer

Dysphagia CafeApril 11, 2021

Dysphagia management in patients with head and neck cancer: Moving beyond tradition

Acute Care

Carmin Bartow, M.S., CCC-SLP, BCS-SMarch 30, 2021

COVID-19 Complications and the Role of the SLP: An Acute Care Case Study

Evidence Based PracticeRehabilitation

Elizabeth Lipton Daly, MS, CCC-SLPMarch 18, 2021

Device-Facilitated Tongue Strengthening Exercise

Continuing Education

Dysphagia CafeMarch 14, 2021

Chronic Cough: Diagnosis to Management

InternationalRehabilitationTreatment

Leticia FreixoFebruary 16, 2021

The Role of Speech-Language Pathology in OSA

Acute CareAdvocacy

Rebecca Brown, M.S.,CCC-SLP,CNTFebruary 4, 2021

A Light in the dark

Acute CareEvidence Based PracticeUncategorized

Gail M. Sudderth, RRTJanuary 31, 2021

Tracheostomy tube cuff management: The road to decannulation

Coffee Break

Ryan HansonJanuary 14, 2021

Crushing and mixing pills to ease swallowing should be avoided. Here are some alternatives.

Coffee Break

Talia Schwartz, MS, CCC-SLPJanuary 2, 2021

Leadership: Empowering and championing by example

From Neuroplasticity to Recovery: The Science and Clinical Application of Pharyngeal Electrical Stimulation (PES)

Elastic Taping in Head & Neck Lymphedema Bundle

Re-Framing the Utility of the Clinical Swallowing Evaluation

INDICATIONS AND USAGE:

VARIBAR ® THIN HONEY (barium sulfate) oral suspension, VARIBAR ® NECTAR (barium sulfate) oral suspension, and VARIBAR ® THIN LIQUID (barium sulfate) for oral suspension, are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients. VARIBAR ® HONEY (barium sulfate) oral suspension and VARIBAR ® PUDDING (barium sulfate) oral paste are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients 6 months of age and older.

IMPORTANT SAFETY INFORMATION:
For Oral Administration. This product should not be used in patients with known or suspected perforation of the GI tract, known obstruction of the GI tract, high risk of aspiration, or hypersensitivity to barium sulfate products. Rarely, severe allergic reactions of anaphylactoid nature have been reported following administration of barium sulfate contrast agents. Aspiration may occur during the modified barium swallow examination, monitor the patient for aspiration.

Please consult full Prescribing Information for VARIBAR products by clicking HERE.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit FDA or call 1-800-FDA-1088.

Type To Search